Visit us through SCI

There is now a new route to our blog through SCI (the Schistosomiasis Control Initiative).

SCI has been rated one of the top two charities for achieving impact with donations by nonprofit organisation GiveWell and Giving What We Can. The Bill and Melinda Gates Foundation awarded SCI $1.5 million to improve control of schistosomiasis last year. They are a fantastic, cost-effective charity that’s worth taking a look at.

We have interviews with Professor Alan Fenwick, Director of SCI, and Professor David Molyneux, adviser to WHO, who have both been working on NTDs for over 25 years coming up in the next few weeks. A brilliant insight into how the world of NTDs has evolved.

Next week we’ll be live-blogging and tweeting from the Royal College of Physicians for the WHO event: Uniting to combat neglected tropical diseases which will feature Bill GatesDirector-General of WHO Dr. Margaret ChanManaging Director of the World Bank Dr. Caroline Anstey, and CEOs of nine leading pharmaceutical companies to name a few!

Stay tuned.

Schistosomiasis Initiative homepage

Schistosomiasis Initiative homepage

Advertisements

This Week in NTDs

What are the thirty ways to live longer? Well, the Telegraph publishes an article this week answering this question. Most of the suggestions are closely linked to the spread of NTD infection. Most critically, at 21, “say no to sandflies” discusses the prevalence of Leishmaniasis and the dangers it proposes.

EndtheNeglect reports on the reemergence of Schistosomiasis in China. They reflect on the reasons for the disease’s return and key issues that need to be considered before action can be taken this time around.

An ex-malaria eradication worker discusses how to combat dengue. This interesting article looks at dengue fever’s spread and how this is key to organising eradication campaigns. Apparently  measures must be taken quickly before outbreaks result in “non-availability of agricultural and industrial labour, crippling the country and ruining its economy”.

Reports from a symposium at the International Centre for Genetic Engineering and Biotechnology (which started on Monday 14th October) have suggested that a dengue vaccine under development at the moment should be ready in six years time.